폴라리스AI파마

041910KOSDAQView the 제약 sectorTheme Bio & healthcare

5,700KRWMarket close of 10/20 (Tue)

Flat 0.00%0KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)5,720KRWUp +0.35%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
5,720
High
5,740
Low
5,560
Day range
Day range low 5,560 high 5,740, open 5,720, close 5,700, previous close 5,700
Volume
1×10K shares
46.31 million KRW 0.25× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 4,300 to 8,920 won, 30% up from the low

30% of the way up from the lowest close in 1 year (252 sessions) · -36.1% from the high

Usual range

Nothing unusual in the 4 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range0.00%0.00%, 0.0× the usual (20-session average ±1.45%)
    That day 0.00% · usual ±1.45% · large-move threshold ±3.0%

The other 3 are within the usual range

  • Trading value0.2×usual range
  • EarningsOperating income, 7 quartersOperating income, 7 quarters
  • Data date10/20 (Tue)Market close
See the full check report

Quarterly results · Q3 2022

  • Revenue14.1B KRWRevenue bars for the last 7 quarters; the dark bar is this quarter
    vs. year ago
    +0.0%
    vs. prior quarter
    +0.7%
  • Operating income822.51 million KRWOperating income bars for the last 7 quarters; the dark bar is this quarter
    vs. year ago
    -48.1%
    vs. prior quarter
    -47.8%
  • Operating margin5.8%Operating margin bars for the last 7 quarters; the dark bar is this quarter
    vs. year ago
    -5.4 pp
    vs. prior quarter
    -5.4 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2023-12-26
2021Q1 1.3B KRW2022Q3 822.51 million KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.